Laatste nieuws in bio

Revolutionizing Bypass Surgery: The Promise of OctoVascular's Vascular Clip

Revolutionizing Bypass Surgery: The Promise of OctoVascular's Vascular Clip

Amsterdam, Thursday, 20 November 2025.
OctoVascular’s innovative vascular clip could transform bypass surgery by reducing recovery time from 12 weeks to 3 weeks, with hospital stays cut to 3 days.

Netherlands' Impact Investors Unveil Healthcare Investment Framework

Netherlands' Impact Investors Unveil Healthcare Investment Framework

Amsterdam, Wednesday, 19 November 2025.
The LIFe-impact framework offers a standardized approach to assess healthcare investments’ societal impact, aiming to increase funding for accessible, quality healthcare in the Netherlands.

Student Researcher Innovates AI Applications in Medicine

Student Researcher Innovates AI Applications in Medicine

Amsterdam, Wednesday, 19 November 2025.
Le Nguyen Phuong Thuy is pioneering AI integration in healthcare, aiming to transform medical diagnostics and patient care in the Netherlands with her award-winning research.

Evaluating Innovation Credit's Impact on Dutch Biotech

Evaluating Innovation Credit's Impact on Dutch Biotech

Amsterdam, Wednesday, 19 November 2025.
HollandBio’s infographic assesses the Innovation Credit’s alignment with biotech needs, highlighting financial challenges and potential for fostering innovation.

Combatting Olive Oil Fraud with DNA Technology in Italy

Combatting Olive Oil Fraud with DNA Technology in Italy

Rome, Tuesday, 18 November 2025.
European experts use portable DNA kits in Italy to fight olive oil fraud, enhancing transparency and consumer trust as food fraud becomes increasingly sophisticated.

AI Revolutionizes Dutch Healthcare with Predictive Technology

AI Revolutionizes Dutch Healthcare with Predictive Technology

Groningen, Monday, 17 November 2025.
Artificial intelligence is transforming healthcare in the Netherlands by improving diagnosis accuracy and reducing costs, enhancing patient care and addressing key system challenges.